M. H. Klingele, S. Brooker
FULL PAPER
needles. Evaporation of the filtrate, and recrystallisation of the
solid residue from 2-propanol gave another 1.35 g (21%) of analyti-
24.0 mmol) in 1-butanol (50 mL), following the procedure de-
scribed above for the preparation of meppt (18), gave 2.49 g (52%)
cally pure material. M.p. 204Ϫ206 °C. C19H15N5 (313.36): calcd. C of analytically pure medpt (19) as colourless flakes. M.p. 175Ϫ177
1
72.84, H 4.80, N 22.47; found C 72.82, H 4.76, N 22.56. H NMR °C. C13H11N5 (237.26): calcd. C 65.81, H 4.67, N 29.52; found C
1
(500 MHz, CDCl3): δ ϭ 2.37 (s, 3 H, CH3), 7.09Ϫ7.14 (m, 4 H, 2-
65.81, H 4.64, N 29.58. H NMR (500 MHz, CDCl3): δ ϭ 4.43 (s,
3
3
4
3
3
4
, 3-, 5- and 6-PhMeH), 7.22 (ddd, J4,5 ϭ 7.7, J5,6 ϭ 4.8, J3,5
ϭ
3 H, CH3), 7.33 (ddd, J4,5 ϭ 7.7, J5,6 ϭ 4.8, J3,5 ϭ 1.2 Hz, 2 H,
2 ϫ 5-PyH), 7.82 (dt, J3,4 ϭ J4,5 ϭ 7.7, J4,6 ϭ 1.8 Hz, 2 H, 2 ϫ
4-PyH), 8.28 (ddd, J3,4 ϭ 7.7, J3,5 ϭ 1.2, J3,6 ϭ 0.9 Hz, 2 H, 2
ϫ 3-PyH), 8.67 (ddd, J5,6 ϭ 4.8, J4,6 ϭ 1.8, J3,6 ϭ 0.9 Hz, 2 H,
3
4
3
3
4
1.2 Hz, 2 H, 2 ϫ 5-PyH), 7.73 (dt, J3,4
ϭ
3J4,5 ϭ 7.7, J4,6
ϭ
1.8 Hz, 2 H, 2 ϫ 4-PyH), 7.98 (ddd, 3J3,4 ϭ 7.7, 4J3,5 ϭ 1.2, 5J3,6 ϭ
0.9 Hz, 2 H, 2 ϫ 3-PyH), 8.40 (ddd, 3J5,6 ϭ 4.8, 4J4,6 ϭ 1.8, 5J3,6 ϭ
3
4
5
3
4
5
0.9 Hz, 2 H, 2 ϫ 6-PyH) ppm. 13C{1H} NMR (125 MHz, CDCl3): 2 ϫ 6-PyH) ppm. 13C{1H} NMR (125 MHz, CDCl3): δ ϭ 34.97
δ ϭ 21.40 (CH3), 124.00 (2 ϫ 5-PyC), 124.71 (2 ϫ 3-PyC), 127.76 (CH3), 124.03 (2 ϫ 5-PyC), 124.48 (2 ϫ 3-PyC), 137.00 (2 ϫ 4-
(2- and 6-PhMeC), 129.31 (3- and 5-PhMeC), 133.67 (1-PhMeC),
PyC), 148.22 (2 ϫ 2-PyC), 148.89 (2 ϫ 6-PyC), 154.22 (3- and 5-
136.59 (2 ϫ 4-PyC), 138.60 (4-PhMeC), 147.20 (2 ϫ 2-PyC), 149.29 TzC) ppm. IR (KBr): ν˜ ϭ 3041, 1586, 1571, 1512, 1485, 1458, 1431,
(2 ϫ 6-PyC), 154.63 (3- and 5-TzC) ppm. IR (KBr): ν˜ ϭ 1582, 1283, 1251, 1146, 1094, 992, 889, 793, 735, 724, 706, 674, 620, 567,
1568, 1541, 1514, 1460, 1444, 1428, 1244, 1173, 1093, 1045, 995,
490 cmϪ1. ESI-MS (pos., MeCN): m/z ϭ 238 [M ϩ H]ϩ, 260 [M
844, 821, 799, 787, 742, 642, 625, 602 cmϪ1. ESI-MS (pos., MeCN): ϩ Na]ϩ, 276 [M ϩ K]ϩ. TLC (SiO2, EtOAc): Rf ϭ 0.12.
m/z ϭ 314 [M ϩ H]ϩ, 336 [M ϩ Na]ϩ, 352 [M ϩ K]ϩ. TLC (SiO2,
Ethyl N-Isobutylpyridine-2-carboximidothioate (20): The reaction of
N-(isobutyl)pyridine-2-thiocarboxamide (11) (9.72 g, 50.0 mmol)
and bromoethane (5.45 g, 50.0 mmol) in the presence of sodium
ethoxide, prepared by dissolving sodium (1.15 g, 50.0 mmol) in dry
ethanol (200 mL), following the procedure described above for the
preparation of ethyl N-(4-methylphenyl)pyridine-2-carboximido-
thioate (14) gave 10.0 g (89%) of crude ethyl N-(isobutyl)pyridine-
2-carboximidothioate (20) as an orange oil. This material could be
used in subsequent reactions without further purification.
C12H18N2S (222.35). 1H NMR (500 MHz, CDCl3): δ ϭ 0.99 [d,
3J ϭ 6.8 Hz, 6 H, NCH2CH(CH3)2], 1.07 (t, 3J ϭ 7.4 Hz, 3 H,
SCH2CH3), 2.08 [non, 3J ϭ 6.8 Hz, 1 H, NCH2CH(CH3)2], 2.75
(q, 3J ϭ 7.4 Hz, 2 H, SCH2CH3), 3.42 [d, 3J ϭ 6.8 Hz, 2 H,
NCH2CH(CH3)2], 7.27 (ddd, 3J4,5 ϭ 7.7, 3J5,6 ϭ 4.8, 4J3,5 ϭ 1.2 Hz,
EtOAc): Rf ϭ 0.13.
Ethyl N-Methylpyridine-2-carboximidothioate (17): The reaction of
N-methylpyridine-2-thiocarboxamide (9) (7.91 g, 50.0 mmol) and
bromoethane (5.45 g, 50.0 mmol) in the presence of sodium ethox-
ide, prepared by dissolving sodium (1.15 g, 50.0 mmol) in dry etha-
nol (200 mL), following the procedure described above for the prep-
aration of ethyl N-(4-methylphenyl)pyridine-2-carboximidothioate
(14) gave 8.39 g (93%) of crude ethyl N-methylpyridine-2-carboxim-
idothioate (17) as an orange oil. This material could be used in
subsequent reactions without further purification. C9H12N2S
(180.27). 1H NMR (500 MHz, CDCl3): δ ϭ 1.07 (t, 3J ϭ 7.4 Hz, 3
H, SCH2CH3), 2.77 (q, 3J ϭ 7.4 Hz, 2 H, SCH2CH3), 3.43 (s, 3 H,
3
3
4
NCH3), 7.27 (ddd, J4,5 ϭ 7.7, J5,6 ϭ 4.8, J3,5 ϭ 1.2 Hz, 1 H, 5-
3
4
5
PyH), 7.55 (ddd, J3,4 ϭ 7.7, J3,5 ϭ 1.2, J3,6 ϭ 0.9 Hz, 1 H, 3-
3
4
5
1 H, 5-PyH), 7.59 (ddd, J3,4 ϭ 7.7, J3,5 ϭ 1.2, J3,6 ϭ 0.9 Hz, 1
3
4
PyH), 7.72 (dt, J3,4
ϭ
3J4,5 ϭ 7.7, J4,6 ϭ 1.8 Hz, 1 H, 4-PyH),
3
4
H, 3-PyH), 7.73 (dt, J3,4
ϭ
3J4,5 ϭ 7.7, J4,6 ϭ 1.8 Hz, 1 H, 4-
3
4
5
8.60 (ddd, J5,6 ϭ 4.8, J4,6 ϭ 1.8, J3,6 ϭ 0.9 Hz, 1 H, 6-PyH)
ppm. 13C{1H} NMR (125 MHz, CDCl3): δ ϭ 15.51 (SCH2CH3),
26.80 (SCH2CH3), 41.27 (NCH3), 122.91 (3-PyC), 123.95 (5-PyC),
136.99 (4-PyC), 148.77 (6-PyC), 156.21 (2-PyC), 165.32 (CNS)
ppm. ESI-MS (pos., MeCN): m/z ϭ 181 [M ϩ H]ϩ.
3
4
5
PyH), 8.61 (ddd, J5,6 ϭ 4.8, J4,6 ϭ 1.8, J3,6 ϭ 0.9 Hz, 1 H, 6-
PyH) ppm. 13C{1H} NMR (125 MHz, CDCl3):
δ ϭ 15.51
(SCH2CH3), 21.58 [NCH2CH(CH3)2], 26.91 (SCH2CH3), 29.82
[NCH2CH(CH3)2], 62.08 [NCH2CH(CH3)2], 123.08 (3-PyC),
123.87 (5-PyC), 137.01 (4-PyC), 148.68 (6-PyC), 156.35 (2-PyC),
163.06 (CNS) ppm. ESI-MS (pos., MeCN): m/z ϭ 223 [M ϩ H]ϩ.
4-Methyl-3-phenyl-5-(2-pyridyl)-4H-1,2,4-triazole (meppt, 18):
A
mixture of crude ethyl N-methylpyridine-2-carboximidothioate (17)
(3.61 g, 20.0 mmol) and benzohydrazide (1) (3.27 g, 24.0 mmol) in
1-butanol (50 mL) was refluxed for 24 h. Evaporation of the reac-
tion mixture, and recrystallisation of the solid residue from ethyl
acetate gave 2.81 g (59%) of analytically pure meppt (18) as colour-
less needles. M.p. 147Ϫ149 °C. C14H12N4 (236.28): calcd. C 71.17,
H 5.12, N 23.71; found C 71.03, H 5.07, N 23.67. 1H NMR
4-Isobutyl-3-phenyl-5-(2-pyridyl)-4H-1,2,4-triazole (ibppt, 21):
A
mixture of crude ethyl N-(isobutyl)pyridine-2-carboximidothioate
(20) (8.89 g, 40.0 mmol) and benzohydrazide (1) (6.13 g,
45.0 mmol) in 1-butanol (100 mL) was refluxed for 24 h. The sol-
vent was evaporated under reduced pressure, and the residue was
dissolved in dichloromethane (100 mL). The solution was washed
with 2 aqueous sodium hydroxide (3 ϫ 50 mL), water (50 mL)
and sat. aqueous sodium chloride (50 mL), and dried with anhy-
drous sodium sulfate. Column chromatography on silica gel eluting
with ethyl acetate/cyclohexane (2:1) gave 7.56 g (67%) of analyti-
cally pure ibppt (21) as a colourless crystalline solid. M.p. 131Ϫ133
°C. C17H18N4 (278.36): calcd. C 73.35, H 6.52, N 20.13; found C
3
(500 MHz, CDCl3): δ ϭ 4.05 (s, 3 H, CH3), 7.34 (ddd, J4,5 ϭ 7.7,
3J5,6 ϭ 4.8, 4J3,5 ϭ 1.2 Hz, 1 H, 5-PyH), 7.48Ϫ7.53 (m, 3 H, 3-, 4-
3
and 5-PhH), 7.66Ϫ7.71 (m, 2 H, 2- and 6-PhH), 7.83 (dt, J3,4
ϭ
3J4,5 ϭ 7.7, J4,6 ϭ 1.8 Hz, 1 H, 4-PyH), 8.33 (ddd, J3,4 ϭ 7.7,
4
3
4J3,5 ϭ 1.2, J3,6 ϭ 0.9 Hz, 1 H, 3-PyH), 8.66 (ddd, J5,6 ϭ 4.8,
5
3
4J4,6 ϭ 1.8, J3,6 ϭ 0.9 Hz, 1 H, 6-PyH) ppm. 13C{1H} NMR
5
1
73.21, H 6.31, N 20.23. H NMR (500 MHz, CDCl3): δ ϭ 0.59 [d,
(125 MHz, CDCl3): δ ϭ 34.34 (CH3), 124.05 (5-PyC), 124.10 (3-
PyC), 127.24 (1-PhC), 128.97 (3- and 5-PhC), 129.31 (2- and 6-
PhC), 130.21 (4-PhC), 137.12 (4-PyC), 148.22 (2-PyC), 148.87 (6-
PyC), 153.46 (5-TzC), 157.00 (3-TzC) ppm. IR (KBr): ν˜ ϭ 3047,
1588, 1569, 1517, 1485, 1470, 1443, 1430, 1278, 1150, 1096, 1076,
991, 927, 889, 789, 779, 773, 737, 722, 706, 699, 668, 623, 578, 485
cmϪ1. ESI-MS (pos., MeCN): m/z ϭ 237 [M ϩ H]ϩ, 259 [M ϩ
Na]ϩ, 275 [M ϩ K]ϩ. TLC (SiO2, EtOAc): Rf ϭ 0.15.
3J ϭ 6.8 Hz, 6 H, CH2CH(CH3)2], 1.71 [non, 3J ϭ 6.8 Hz, 1 H,
CH2CH(CH3)2], 4.51 [d, 3J ϭ 6.8 Hz, 2 H, CH2CH(CH3)2], 7.34
3
3
4
(ddd, J4,5 ϭ 7.7, J5,6 ϭ 4.8, J3,5 ϭ 1.2 Hz, 1 H, 5-PyH),
7.49Ϫ7.54 (m, 3 H, 3-, 4- and 5-PhH), 7.61Ϫ7.65 (m, 2 H, 2- and
3
3
4
6-PhH), 7.84 (dt, J3,4 ϭ J4,5 ϭ 7.7, J4,6 ϭ 1.8 Hz, 1 H, 4-PyH),
8.33 (ddd, J3,4 ϭ 7.7, J3,5 ϭ 1.2, J3,6 ϭ 0.9 Hz, 1 H, 3-PyH),
3
4
5
3
4
5
8.65 (ddd, J5,6 ϭ 4.8, J4,6 ϭ 1.8, J3,6 ϭ 0.9 Hz, 1 H, 6-PyH)
ppm. 13C{1H} NMR (125 MHz, CDCl3):
δ
ϭ
19.59
4-Methyl-3,5-di(2-pyridyl)-4H-1,2,4-triazole (medpt, 19): The reac-
tion of crude ethyl N-methylpyridine-2-carboximidothioate (17)
[CH2CH(CH3)2], 29.74 [CH2CH(CH3)2], 52.46 [CH2CH(CH3)2],
124.06 (5-PyC), 124.12 (3-PyC), 128.06 (1-PhC), 128.97 (3- and 5-
(3.61 g, 20.0 mmol) and pyridine-2-carbohydrazide (2) (3.29 g, PhC), 129.59 (2- and 6-PhC), 130.06 (4-PhC), 137.15 (4-PyC),
Eur. J. Org. Chem. 2004, 3422Ϫ3434